Bacterial endotoxin (lipopolysaccharide) binds to the surface of gold nanoparticles, interferes with biocorona formation and induces human monocyte inflammatory activation

References

• Bachman, J. A., and P. Sorger. 2011. “New Approaches to Modeling Complex Biochemistry.” Nature Methods 8: 130.
   PubMed Web of Science ®Google Scholar
• Bastús, N. G., E. Casals, S. Vázquez-Campos, and V. Puntes. 2008. “Reactivity of Engineered Inorganic Nanoparticles and Carbon Nanostructures in Biological Media.” Nanotoxicology 2: 99–112.
   Web of Science ®Google Scholar
• Bastús, N. G., J. Comenge, and V. Puntes. 2011. “Kinetically Controlled Seeded Growth Synthesis of Citrate-Stabilized Gold Nanoparticles of up to 200 nm: Size Focusing Versus Ostwald Ripening.” Langmuir 27: 11098–11105.
   PubMed Web of Science ®Google Scholar
• Bonabeau, E. 2002. “Agent-Based Modeling: Methods and Techniques for Simulating Human Systems.” Proceedings of the National Academy of Sciences 99: 7280–7287.
   PubMed Web of Science ®Google Scholar
• Boraschi, D., and A. Duschl. 2012. Immune System. In Adverse Effects of Engineered Nanomaterials, edited by B. Fadeel, A. Pietroiusti, and A.A. Shvedova, 169–184. Amsterdam: Academic Press.
   Google Scholar
• Bromberg, L., E. P. Chang, C. Alvarez-Lorenzo, B. Magarinos, A. Concheiro, and T. A. Hatton. 2010. “Binding of Functionalized Paramagnetic Nanoparticles to Bacterial Lipopolysaccharides and DNA.” Langmuir 26: 8829–8835.
   PubMed Web of Science ®Google Scholar
• Casals, E., T. Pfaller, A. Duschl, G. J. Oostingh, and V. Puntes. 2010. “Time Evolution of the Nanoparticle Protein Corona.” ACS Nano 4: 3623–3632.
   PubMed Web of Science ®Google Scholar
• Casals, E., and V. F. Puntes. 2012. “Inorganic Nanoparticle Biomolecular Corona: Formation, Evolution and Biological Impact.” Nanomedicine 7: 1917–1930.
   PubMed Web of Science ®Google Scholar
• Choi, K., J. E. Riviere, and N. A. Monteiro-Riviere. 2016. “Protein Corona Modulation of Hepatocyte Uptake and Molecular Mechanisms of Gold Nanoparticle Toxicity.” Nanotoxicology 11: 64–75.
   PubMed Web of Science ®Google Scholar
• Darkow, R., T. Groth, W. Albrecht, K. Lützow, and D. Paul. 1999. “Functionalized Nanoparticles for Endotoxin Binding in Aqueous Solutions.” Biomaterials 20: 1277–1283.
   PubMed Web of Science ®Google Scholar
• Dinarello, C. A. 2009. “Immunological and Inflammatory Functions of the Interleukin-1 Family.” Annual Review of Immunology 27: 519–550.
   PubMed Web of Science ®Google Scholar
• Dinarello, C. A. 2011. “Interleukin-1 in the Pathogenesis and Treatment of Inflammatory Diseases.” Blood 117: 3720.
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia, M. A., P. Aggarwal, J. B. Hall, and S. E. Mcneil. 2008. “Preclinical Studies to Understand Nanoparticle Interaction with the Immune System and its Potential Effects on Nanoparticle Biodistribution.” Molecular Pharmaceutics 5: 487–495.
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia, M. A., D. R. Germolec, and J. L. Weaver. 2009. “Evaluation of Nanoparticle Immunotoxicity.” Nature Nanotechnology 4: 411–414.
   PubMed Web of Science ®Google Scholar
• Ge, C., Y. Li, J. J. Yin, Y. Liu, L. Wang, Y. Zhao, and C. Chen. 2012. “The Contributions of Metal Impurities and Tube Structure to the Toxicity of Carbon Nanotube Materials.” NPG Asia Materials 4: e32.
   Web of Science ®Google Scholar
• Gorbet, M. B., and M. V. Sefton. 2005. “Endotoxin: The Uninvited Guest.” Biomaterials 26: 6811–6817.
   PubMed Web of Science ®Google Scholar
• Janeway, C. A., and R. Medzhitov. 2002. “Innate Immune Recognition.” Annual Review of Immunology 20: 197–216.
   PubMed Web of Science ®Google Scholar
• Joosten, L. A., M. G. Netea, and C. A. Dinarello. 2013. “Interleukin-1β in Innate Inflammation, Autophagy and Immunity.” Seminars in Immunology 25: 416–424.
   PubMed Web of Science ®Google Scholar
• Latz, E. 2010. “The Inflammasomes: Mechanisms of Activation and Function.” Current Opinion in Immunology 22: 28–33.
   PubMed Web of Science ®Google Scholar
• Li, Y., and D. Boraschi. 2016. “Endotoxin Contamination: A Key Element in the Interpretation of Nanosafety Studies.” Nanomedicine 11: 269–287.
   PubMed Web of Science ®Google Scholar
• Li, Y., M. Fujita, and D. Boraschi. 2017. “Endotoxin Contamination in Nanomaterials Leads to the Misinterpretation of Immunosafety Results.” Frontiers in Immunology 8: 472.
   PubMed Web of Science ®Google Scholar
• Li, Y., P. Italiani, E. Casals, N. Tran, V. F. Puntes, and D. Boraschi. 2015. “Optimising the Use of Commercial LAL Assays for the Analysis of Endotoxin Contamination in Metal Colloids and Metal Oxide Nanoparticles.” Nanotoxicology 9: 462–473.
   PubMed Web of Science ®Google Scholar
• Li, Y., P. Italiani, E. Casals, D. Valkenborg, I. Mertens, G. Baggerman, I. Nelissen, V. Puntes, and D. Boraschi. 2016. “Assessing the Immunosafety of Engineered Nanoparticles with a Novel In Vitro Model Based on Human Primary Monocytes.” ACS Applied Materials & Interfaces 8: 28437–28447.
   PubMed Web of Science ®Google Scholar
• Li, Y., Y. Liu, Y. Fu, T. Wei, L. Le Guyader, G. Gao, R. S. Liu, Y. Z. Chang, and C. Chen. 2012. “The Triggering of Apoptosis in Macrophages by Pristine Graphene Through the MAPK and TGF-Beta Signaling Pathways.” Biomaterials 33: 402–411.
   PubMed Web of Science ®Google Scholar
• Li, Y., and N. A. Monteiro-Riviere. 2016. “Mechanisms of Cell Uptake, Inflammatory Potential and Protein Corona Effects with Gold Nanoparticles.” Nanomedicine 11: 3185–3203.
   PubMed Web of Science ®Google Scholar
• Li-Weber, M., M. Giasi, and P. H. Krammer. 1998. “Involvement of Jun and Rel Proteins in Up-Regulation of Interleukin-4 Gene Activity by the T Cell Accessory Molecule CD28.” Journal of Biological Chemistry 273: 32460–32466.
   PubMed Web of Science ®Google Scholar
• Lundqvist, M., J. Stigler, G. Elia, I. Lynch, T. Cedervall, and K. A. Dawson. 2008. “Nanoparticle Size and Surface Properties Determine the Protein Corona with Possible Implications for Biological Impacts.” Proceedings of the National Academy of Sciences 105: 14265–14270.
   PubMed Web of Science ®Google Scholar
• Monopoli, M. P., D. Walczyk, A. Campbell, G. Elia, I. Lynch, F. Baldelli Bombelli, and K. A. Dawson. 2011. “Physical-Chemical Aspects of Protein Corona: Relevance to In Vitro and In Vivo Biological Impacts of Nanoparticles.” Journal of the American Chemical Society 138: 2525–2534.
   Google Scholar
• Murali, K., K. Kenesei, Y. Li, K. Demeter, Z. Környei, and E. Madarász. 2015. “Uptake and Bio-Reactivity of Polystyrene Nanoparticles is Affected by Surface Modifications, Ageing and LPS Adsorption: In Vitro Studies on Neural Tissue Cells.” Nanoscale 7: 4199–4210.
   PubMed Web of Science ®Google Scholar
• Murphy, K. M. 2012. Janeway’s Immunobiology. 8th ed. New York: Garland Science.
   Google Scholar
• Netlogo. 2014. Netlogo. 5.1.0 ed. https://ccl.northwestern.edu/netlogo/5.1.0/
   Google Scholar
• Oostingh, G. J., E. Casals, P. Italiani, R. Colognato, R. Stritzinger, J. Ponti, T. Pfaller, Y. Kohl, D. Ooms, and F. Favilli. 2011. “Problems and Challenges in the Development and Validation of Human Cell-Based Assays to Determine Nanoparticle-Induced Immunomodulatory Effects.” Particle and Fibre Toxicology 8: 8.
   PubMed Web of Science ®Google Scholar
• Owens, D. E., and N. A. Peppas. 2006. “Opsonization, Biodistribution, and Pharmacokinetics of Polymeric Nanoparticles.” International Journal of Pharmaceutics 307: 93–102.
   PubMed Web of Science ®Google Scholar
• Peula-García, J., J. Molina-Bolivar, J. Velasco, A. Rojas, and F. Galisteo-González. 2002. “Interaction of Bacterial Endotoxine (lipopolysaccharide) with Latex Particles: Application to Latex Agglutination Immunoassays.” Journal of Colloid and Interface Science 245: 230–236.
   PubMed Web of Science ®Google Scholar
• Pfaffl, M. W. 2001. “A New Mathematical Model for Relative Quantification in Real-Time RT-PCR.” Nucleic Acids Research 29: e45.
   PubMed Web of Science ®Google Scholar
• Salvati, A., A. S. Pitek, M. P. Monopoli, K. Prapainop, F. B. Bombelli, D. R. Hristov, P. M. Kelly, C. Åberg, E. Mahon, and K. A. Dawson. 2013. “Transferrin-Functionalized Nanoparticles Lose Their Targeting Capabilities when a Biomolecule Corona Adsorbs on the Surface.” Nature Nanotechnology 8: 137–143.
   PubMed Web of Science ®Google Scholar
• Savolainen, K., U. Backman, D. Brouwer, B. Fadeel, T. Fernandes, T. Kuhlbusch, R. Landsiedel, I. Lynch, and L. Pylkkänen. 2013. Nanosafety in Europe 2015-2025: Towards Safe and Sustainable Nanomaterials and Nanotechnology Innovations. Helsinki: Finnish institute of occupational Health.
   Google Scholar
• Schwarz, H., M. Schmittner, A. Duschl, and J. Horejs-Hoeck. 2014. “Residual Endotoxin Contaminations in Recombinant Proteins are Sufficient to Activate Human CD1c + Dendritic Cells.” PloS One 9: e113840.
   PubMed Web of Science ®Google Scholar
• Shi, Z., S. K. Chapes, D. Ben-Arieh, and C.-H. Wu. 2016. “An Agent-Based Model of a Hepatic Inflammatory Response to Salmonella: A Computational Study Under a Large Set of Experimental Data.” PloS One 11: e0161131.
   PubMed Web of Science ®Google Scholar
• Shi, Z. Z., C.-H. Wu, and D. Ben-Arieh. 2014. “Agent-Based Model: A Surging Tool to Simulate Infectious Diseases in the Immune System.” Open Journal of Modelling and Simulation 2: 12–22.
   Google Scholar
• Turkevich, J., P. C. Stevenson, and J. Hillier. 1955. “A Study of the Nucleation and Growth Processes in the Synthesis of Colloidal Gold.” Discussions of the Faraday Society 11: 55–75.
   Google Scholar
• Vallhov, H., J. Qin, S. M. Johansson, N. Ahlborg, M. A. Muhammed, A. Scheynius, and S. Gabrielsson. 2006. “The Importance of an Endotoxin-Free Environment During the Production of Nanoparticles Used in Medical Applications.” Nano Letters 6: 1682–1686.
   PubMed Web of Science ®Google Scholar
• Wang, P., X. Nie, Y. Wang, Y. Li, C. Ge, L. Zhang, L. Wang, et al. 2013. “Multiwall Carbon Nanotubes Mediate Macrophage Activation and Promote Pulmonary Fibrosis Through TGF-β/Smad Signaling Pathway.” Small 9: 3799–3811.
   PubMed Web of Science ®Google Scholar